Related Experiment Videos
An endothelial receptor for oxidized low-density lipoprotein
1Department of Pharmacology, Faculty of Medicine, Kyoto University, Japan.
Nature
|March 6, 1997
Summary
Researchers identified a novel receptor in vascular endothelial cells that binds oxidatively modified low-density lipoprotein (Ox-LDL). This discovery sheds light on atherosclerosis pathogenesis and Ox-LDL uptake mechanisms.
Area of Science:
- Cardiovascular Biology
- Molecular Cell Biology
- Atherosclerosis Research
Background:
- Oxidatively modified low-density lipoprotein (Ox-LDL) contributes to atherosclerosis by impairing endothelial function.
- Ox-LDL affects nitric oxide production and promotes inflammatory molecule expression in endothelial cells.
- Endothelial cells internalize Ox-LDL via a receptor-mediated pathway distinct from macrophage scavenger receptors.
Purpose of the Study:
- To identify and clone the specific receptor responsible for Ox-LDL uptake in vascular endothelial cells.
- To characterize the molecular nature and tissue distribution of this Ox-LDL receptor.
Main Methods:
- Utilized an expression cloning strategy to isolate the Ox-LDL receptor.
- Performed molecular cloning and structural analysis of the identified receptor.
- Investigated the receptor's expression in vivo within vascular endothelium and other tissues.
Main Results:
- Successfully cloned a novel Ox-LDL receptor from vascular endothelial cells.
- The cloned receptor is a membrane protein belonging to the C-type lectin family.
- Demonstrated in vivo expression of the receptor in vascular endothelium and vascular-rich organs.
Conclusions:
- A novel C-type lectin family receptor for Ox-LDL has been identified in vascular endothelial cells.
- This receptor plays a role in the uptake of Ox-LDL by endothelial cells, independent of macrophage scavenger receptors.
- The findings provide new insights into the molecular mechanisms of Ox-LDL handling in atherogenesis.